BMB-101 demonstrated significant anti-seizure benefit in both cohorts with favorable safety and tolerability Absence: 73.1% ...

AIIMS Delhi has resumed free Therapeutic Drug Monitoring (TDM) tests for epilepsy patients. This initiative reduces financial ...

Bright Minds Biosciences has debuted glowing phase 2 results for its lead anti-seizure asset, giving the biotech’s stock a ...

Shares of Bright Minds Biosciences rose after the company released positive topline results from its phase two trial of a treatment for patients with drug-resistant Absence Seizures and Developmental ...

Biosciences announced positive and significant topline results from its Phase 2 BREAKTHROUGH clinical trial evaluating ...

In the case of Tamiflu, new research is offering relief and good news for parents and children. The latest study data ...

The trial had 24 patients, exceeding the original target of 20, and included a 4-week baseline. ・In the Absence cohort, ...

Medical professionals revealed the growth was terminal and gave Sean merely 10 years to live. After enduring five weeks of ...

The All India Institute of Medical Sciences has introduced a free therapeutic drug monitoring test for patients with epilepsy ...

Sean Ryan Sweeney, 31, was diagnosed with a grade 3 astrocytoma after suffering from frequent headaches, neck pain and a ...

He recalled: "Then, everything escalated suddenly. I was woken in the early hours by my partner, Lucy (now my wife), after I ...

He thought he'd torn a ligament in his neck while running or weight training and went to a physiotherapist, but had no relief ...